Inside the legal fight over the telehealth clinics that help women defy abortion bans
Every month, thousands of women thwart abortion bans in their home states by turning to telehealth clinics willing to prescribe pregnancy-ending drugs online and ship them anywhere in the country.
Whether this is legal, though, is a matter of debate. Two legal cases involving a New York doctor could wind up testing the shield laws some states have passed to protect telehealth providers who ship abortion pills nationwide.
Dr. Margaret Carpenter faces a felony charge in Louisiana for supplying abortion medication through the mail to a pregnant teen in that state. The patient's mother also faces criminal charges. A Texas judge fined the same physician $100,000 after the state accused her of prescribing abortion medication for a woman near Dallas.
So far, the prosecution hasn't progressed thanks to New York's shield law, which has protected Carpenter from extradition to Louisiana. But other telehealth centers operating in states with similar legal protections for abortion providers are watching closely.
'We have great legal counsel who have advised us that what we are doing is legal,' said Dr. Angel Foster, co-founder of The Massachusetts Medication Abortion Access Project, which is among a handful of telehealth providers that facilitate abortions from afar in states with bans.
As more states consider enacting shield laws or expanding existing ones, whether one state can shield providers from liability for breaking another state's laws around abortion is still an unsettled area of law.
Erik Baptist, senior counsel for the Alliance Defending Freedom, which opposes abortion, said shield laws violate a constitutional requirement that states respect the laws and legal judgments of other states.
'What these shield law states are doing are undermining the prerogative of these pro-life states to implement and enforce pro-life laws,' said Baptist, director of the group's Center for Life. 'And so I think the Supreme Court ultimately will want to take this.'
'That is inherently a challenge with shield laws and telehealth,' said Carmel Shachar, faculty director of the Health Law and Policy Clinic at Harvard Law School. 'At a certain point, for the purposes of abortion bans, the courts will need to decide: Do we treat a telehealth abortion as happening within the state of the provider or within the state of the patient?'
Abortion pills sent to your home
Decades ago, the FDA approved the use of two prescription medicines — mifepristone and misoprostol — to terminate pregnancies.
But it wasn't until 2023 that telehealth abortions across states became more popular, after the U.S. Supreme Court overturned Roe v. Wade in 2022.
The Society of Family Planning, which supports abortion rights, said that between April and June 2024 there were an average of 7,700 telehealth abortions performed each month in states that either ban abortion totally or after six weeks of pregnancy.
The prescribing process at telehealth clinics varies by provider, but usually takes place entirely online, with the patient answering a series of health-related questions and consent forms.
At some telehealth clinics, medical providers don't come face-to-face with patients, even via videoconferencing, and patients don't necessarily know the prescriber's name unless requested.
For instance, when Foster's clinic, also known as The MAP, puts pills in the mail, only the name of the practice appears on the label, as allowed under the Massachusetts shield law. If patients have follow-up questions, they can talk or text the doctor working that day, but may not know that doctor's name either.
Pills can arrive in a less than a week.
'This has been the safety net, post-Dobbs, of allowing people who don't have the ability to travel out of state to get abortion care,' said Greer Donley, a University of Pittsburgh law professor and abortion law expert.
When dealing with medications not related to abortion, doctors are often able to write prescriptions for patients in other states. However, in most states, if the patient is located within its borders, the doctor must have a license issued by that state, according to Mei Wa Kwong, executive director of the The Center for Connected Health Policy.
States with shield laws
Twenty three states and Washington, D.C., currently have shield laws protecting abortion providers.
Of those, eight have specific provisions protecting them from criminal prosecution or civil lawsuits even if the patient is in another state, according to the nonprofit research organization KFF. They include California, Colorado, Maine, Massachusetts, New York, Rhode Island, Vermont and Washington.
Louisiana's request to extradite Carpenter hit a roadblock when New York Gov. Kathy Hochul rejected it, citing the state's shield law. (A county clerk also cited the shield law as he refused to file the civil judgment from Texas.)
'These are not doctors providing health care. They are drug dealers,' Republican Louisiana Attorney General Liz Murrill told state lawmakers as she promoted a bill that would expand who can sue and be sued in abortion medication cases. 'They are violating our laws. They are sending illegal medications for purposes of procuring abortions that are illegal in our state.'
Clinics say they will keep prescribing
Julie Kay, the executive director of the Abortion Coalition for Telemedicine, the nationwide organization co-founded by Carpenter, said providers won't be 'bullied and intimidated' into ceasing operations.
Other telehealth abortion providers said they also won't be deterred by legal threats.
'I have been working in this field for 25 years and this is part of the work,' said Dr. Rebecca Gomperts, founder and director of Aid Access, an abortion pill supplier. 'It's something that we all anticipated would happen,' she said of the legal challenges.
A doctor who is part of A Safe Choice, a network of California-based physicians that prescribes abortion pills to women in all 50 states, told The Associated Press he believes he is protected by the state's shield law, but is also taking precautions.
'I'm not going to be traveling outside of California for a very long time,' said the doctor, who spoke with The Associated Press on condition of anonymity because he wanted to protect his identity for safety reasons.
___
Associated Press writer Sara Cline in Baton Rouge, Louisiana, contributed to this report.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
an hour ago
- Miami Herald
Lilly's experimental obesity drug shows promise in early study
An experimental weight-loss drug from Eli Lilly & Co. helped patients lose weight with few side effects, according to the summary of a small study that suggests the company has another foothold in the obesity market. The drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months, according to an abstract posted Friday ahead of the American Diabetes Association conference in Chicago. The drug is moving to the next stage of development and researchers will present details on dosing and safety at the conference next week. "The data look particularly strong, and should push the program back into investor conversations," Cantor Fitzgerald analyst Prakhar Agrawal wrote in a note to investors. Lilly has shared few details about eloralintide before now, as it's still in the early stages of testing. It's part of a class of drugs that mimic the hormone amylin, which slows digestion and makes people feel full longer. They're thought to be a gentler option for losing weight than currently available injections like Zepbound and Wegovy, which often have side effects like nausea and vomiting. The study enrolled 100 patients who were given different doses of the experimental drug or a placebo for 12 weeks. Weight loss ranged from 2.6% to 11.3%, according to the abstract. Gastrointestinal side effects were relatively minimal, with about 10% of patients experiencing diarrhea and 8% vomiting. Few details were provided, however, including information on risks and benefits based on dose. The promise of drugs that are easier to take than blockbusters like Lilly's Zepbound and its rival Wegovy, from Novo Nordisk A/S, has drawn increasing interest from companies hoping for a piece of pharma's hottest market. In March, Roche Holding AG entered into a $5.3 billion deal to co-develop and commercialize Zealand Pharma A/S' amylin drug, called petrelintide. It is seen as the one to beat in the amylin class, with early trials showing patients lost as much as 8.6% of their body weight in four months, with less nausea than Lilly and Novo's current therapies. AbbVie Inc. agreed to pay as much as $2.2 billion in March for an amylin drug from Danish biotech Gubra A/S, marking its first foray into the obesity market. New York-based startup Metsera Inc. is developing a related compound that may be taken less frequently than weekly shots like Zepbound and Wegovy. Lilly is already a leader in the obesity market, where Zepbound is capturing the majority of new prescriptions. The company has several promising next-generation products in the late stages of development, including a pill called orforglipron and an experimental shot that's thought to be even more effective for weight loss. The company is studying eloralintide alone and in combination with Zepbound - similar to the approach Novo is taking with its next-generation drug CagriSema, which combines an amylin component with semaglutide, the backbone of Wegovy and the diabetes drug Ozempic. Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.
Associated Press
an hour ago
- Associated Press
Notification of Data Security Incident
LAS VEGAS, June 13, 2025 /PRNewswire/ -- Effortless Office Enterprises, LLC ('Effortless Office') has learned of a data security incident that may have involved personal and/or protected health information of certain employees and patients of Nevada Heart and Vascular ('NHV'). Notice of this incident has been sent to certain affected current/former employees, patients, and/or associated parties and provided resources to assist them. Upon learning of suspicious activity temporarily within its computer network, Effortless Office promptly took steps to secure the environment and began an investigation to determine the nature and scope of the issue. In addition, they began working to restore impacted systems as quickly as possible and engaged digital forensics specialists to conduct an investigation. The investigation determined that unauthorized access occurred at certain times between May 9, 2024 and July 23, 2024. After determining that personal information may have been impacted, Effortless Office completed a comprehensive programmatic and manual review to identify what personal information was impacted and to whom it belonged. On May 12, 2025, Nevada Heart & Vascular Center, LLP learned that certain personal information was impacted in connection with the incident. The following information may have been affected as a result of the incident: Social Security number, taxpayer identification number, driver's license or state identification, passport number, date of birth, account number, routing number, security code, payment card number, payment card pin, payment card expiration date, health insurance information, medical information, and biometric data. On June 13, 2025, a notification letter was mailed to affected individuals, for whom address information was available. A toll-free call center has been established to answer questions about the incident and address related concerns. Call center representatives are available Monday through Friday from 9:00 am to 9:00 pm Eastern Time and can be reached at 1-855-200-7910. The privacy and protection of personal and protected health information is a top priority for Effortless Office, which deeply regrets any inconvenience or concern this incident may cause. View original content: SOURCE Effortless Office Enterprises, LLC
Health Line
2 hours ago
- Health Line
Can a Hemorrhoid Burst and Is It Dangerous?
Both external and internal hemorrhoids can become thrombosed, meaning a blood clot forms inside the vein. If the clot becomes too full of blood, the hemorrhoid could rupture, which can lead to severe pain, though it does not usually jeopardize your health or life. Hemorrhoids, also called piles, are enlarged veins in your rectum and anus. Some people may not experience symptoms from piles, but others may have itching, burning, bleeding, and discomfort, especially when sitting down. There are two types of hemorrhoids: Internal hemorrhoids develop in your rectum. External hemorrhoids develop around the anal opening, beneath the skin. Read on to learn more about burst hemorrhoids, including what happens and what you should do. What happens when a hemorrhoid bursts? When a thrombosed hemorrhoid becomes too full of blood, it may burst. This can lead to a brief period of bleeding. Ruptured hemorrhoids are not typically dangerous or considered a medical emergency. A thrombosed hemorrhoid will typically become very painful before it actually bursts. Once it bursts, you'll likely feel an instant sense of relief due to the release of extra pressure from built-up blood. How long will the bleeding from a burst hemorrhoid last? Bleeding from a burst hemorrhoid can last anywhere from a few seconds to several minutes. However, it shouldn't last for more than 10 minutes. In some cases, the area around the hemorrhoid may continue to bleed occasionally during or after bowel movements. What should you do if a hemorrhoid bursts? A burst hemorrhoid usually doesn't require any medical treatment. But you may want to take a sitz bath to soothe the area and keep it clean while it heals. A sitz bath can also help to increase blood flow to the area, which aids the healing process. To take a sitz bath, try these steps: Fill a clean bathtub with 3 to 4 inches of warm water — make sure it's not too hot. Sit in the water and soak the area for 15 to 20 minutes. Try bending your knees or putting your legs over the edge of the tub to ensure the area is submerged. Gently pat dry the area with a clean towel, making sure you don't rub or scrub. Over the next week, try to keep the area clean and dry. While a shower or bath should be enough, you can also take a daily sitz bath. »MORE ON THIS: All about sitz baths When to see a doctor It's always a good idea to have a medical evaluation when you have anal bleeding. If bleeding lasts for more than 10 minutes, or is recurrent or severe, it's best to seek immediate care to rule out other causes. Not all bleeding is due to hemorrhoids, so it's important not to self-diagnose. Sometimes, bleeding can caused by a minor injury or tear, or it could be a symptom of an underlying condition, such as colorectal or anal cancer. In addition to anal bleeding, these accompanying symptoms also warrant care: sudden and persistent changes in stool consistency or color changes in bowel movement habits anal pain or cramping unexplained weight loss nausea or vomiting fever dizziness lightheadedness abdominal pain An irritated hemorrhoid can also cause intermittent bleeding over a longer period of time, but it would not be accompanied by any of these other symptoms. What's the outlook for a burst hemorrhoid? The blood from a burst hemorrhoid can look alarming, but it's usually not serious. However, a hemorrhoid that is filled with blood will be extremely painful, leading up to when it bursts. This pain is severe enough that most people seek treatment before the hemorrhoid has a chance to burst. Burst hemorrhoids usually resolve quickly and may or may not return. If you didn't have any unusual pain leading up to the bleeding, you may have just irritated an inflamed hemorrhoid. Takeaway
